Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Financial Summary: BRIEF: For the three months ended 31 January 2025, Agilent Technologies Inc revenues increased 1% to $1.68B. Net income decreased 9% to $318M. Revenues reflect Life Sciences and Diagnostics Markets segment increase of 4% to $647M, Agilent CrossLab segment increase of 1% to $696M, United States segment increase of 6% to $669M, Europe segment increase of 1% to $463M. Net income was offset by Applied Markets segment income decrease of 9% to $84M.